For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $20.20 in the last session, down -5.92% from day before closing price of $21.47. In other words, the price has decreased by -$5.92 from its previous closing price. On the day, 3.21 million shares were traded. ADMA stock price reached its highest trading level at $21.3345 during the session, while it also had its lowest trading level at $20.18.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 55.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.15. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 09 ’24 when Guiheen Lawrence P. sold 9,000 shares for $18.47 per share. The transaction valued at 166,189 led to the insider holds 153,941 shares of the business.
Guiheen Lawrence P. bought 9,000 shares of ADMA for $146,340 on Sep 09 ’24. On Aug 30 ’24, another insider, Kestenberg-Messina Kaitlin M., who serves as the COO and SVP, Compliance of the company, sold 24,150 shares for $16.90 each. As a result, the insider received 408,050 and left with 449,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4775078400 and an Enterprise Value of 4799759872. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 73.11, and their Forward P/E ratio for the next fiscal year is 27.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.47 while its Price-to-Book (P/B) ratio in mrq is 20.59. Its current Enterprise Value per Revenue stands at 12.538 whereas that against EBITDA is 38.125.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is 9.26%, while the 200-Day Moving Average is calculated to be 71.25%.
Shares Statistics:
According to the various share statistics, ADMA traded on average about 5.15M shares per day over the past 3-months and 5134510 shares per day over the past 10 days. A total of 236.39M shares are outstanding, with a floating share count of 228.39M. Insiders hold about 3.38% of the company’s shares, while institutions hold 88.47% stake in the company. Shares short for ADMA as of 1730332800 were 15198480 with a Short Ratio of 2.95, compared to 1727654400 on 17079555. Therefore, it implies a Short% of Shares Outstanding of 15198480 and a Short% of Float of 6.6199996.
